NuVasive, Inc. (NUVA) Social Stream
NUVASIVE INC (NUVA) Price Targets From Analysts
Use the tables below to see what analysts covering NUVASIVE INC think about its future price and what recommendations they have for investors and traders.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-10 | 11 | $90 | $48 | $69.583 | $39.75 | 75.05% |
2021-11-16 | 11 | $90 | $48 | $67.083 | $39.75 | 68.76% |
2021-12-10 | 12 | $90 | $48 | $66.538 | $39.75 | 67.39% |
2021-12-17 | 9 | $90 | $50 | $67.909 | $39.75 | 70.84% |
2021-12-21 | 9 | $90 | $50 | $66.545 | $39.75 | 67.41% |
2022-01-25 | 9 | $90 | $50 | $66.363 | $39.75 | 66.95% |
2022-02-15 | 8 | $90 | $50 | $66.363 | $39.75 | 66.95% |
2022-02-24 | 9 | $90 | $50 | $66.5 | $39.75 | 67.3% |
2022-02-25 | 9 | $80 | $50 | $62.222 | $39.75 | 56.53% |
2022-04-11 | 10 | $80 | $50 | $61.8 | $39.75 | 55.47% |
2022-04-26 | 10 | $80 | $50 | $62.3 | $39.75 | 56.73% |
2022-05-06 | 9 | $80 | $55 | $63.5 | $39.75 | 59.75% |
2022-08-02 | 9 | $80 | $54 | $62 | $39.75 | 55.97% |
2022-09-17 | 9 | $65 | $54 | $59.545 | $39.75 | 49.8% |
2022-10-03 | 10 | $65 | $45 | $57.636 | $39.75 | 45% |
2022-10-05 | 10 | $65 | $45 | $58.083 | $39.75 | 46.12% |
2022-10-07 | 11 | $65 | $45 | $57.666 | $39.75 | 45.07% |
2022-10-11 | 12 | $65 | $45 | $56.923 | $39.75 | 43.2% |
2022-10-12 | 12 | $65 | $45 | $56.071 | $39.75 | 41.06% |
2022-10-18 | 13 | $65 | $45 | $55.866 | $39.75 | 40.54% |
2022-12-14 | 13 | $63 | $38 | $50.533 | $39.75 | 27.13% |
2023-01-06 | 13 | $63 | $38 | $49.6 | $39.75 | 24.78% |
2023-01-26 | 13 | $63 | $38 | $49.6 | $39.75 | 24.78% |
2023-02-08 | 12 | $63 | $38 | $49.8 | $39.75 | 25.28% |
2023-02-10 | 12 | $63 | $38 | $51.281 | $39.75 | 29.01% |
2023-02-15 | 13 | $58 | $38 | $49.881 | $39.75 | 25.49% |
2023-02-24 | 13 | $58 | $42 | $50.648 | $39.75 | 27.42% |
2023-05-10 | 13 | $58 | $42 | $50.248 | $39.75 | 26.41% |
2023-05-15 | 13 | $58 | $42 | $50.114 | $39.75 | 26.07% |
2023-05-30 | 13 | $58 | $40 | $50.114 | $39.75 | 26.07% |
2023-07-19 | 13 | $58 | $40 | $50.314 | $39.75 | 26.58% |
2023-08-03 | 13 | $68 | $42 | $51.551 | $39.75 | 29.69% |
2023-08-07 | 13 | $68 | $42 | $51.837 | $39.75 | 30.41% |
The Trend in the Analyst Price Target
NUVA's average price target has moved down $14.56 over the prior 38 months.
Over the past 47 weeks, NUVA's average upside potential has been 24.56%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-10-03 | 10 | 65 | 45 | 57.636 | 43.96 | 31.11% |
2023-01-06 | 13 | 63 | 38 | 49.600 | 42.79 | 15.91% |
2023-01-26 | 13 | 63 | 38 | 49.600 | 44.95 | 10.34% |
2023-05-30 | 13 | 58 | 40 | 50.114 | 36.71 | 36.51% |
2023-07-19 | 13 | 58 | 40 | 50.314 | 43.14 | 16.63% |
NUVA Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
2.46 | 3 | 1 | 9 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
NUVA's average broker recommendation rating worsened by 0.46 over the prior 39 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, NUVASIVE INC's number of analysts covering the stock is higher than 3460.53% of them.
- In terms of how NUVASIVE INC fares relative to stocks in the mid market cap category, note that its average analyst price target is greater than 2947.03% of that group.
- In the context of Healthcare stocks, NUVASIVE INC's upside potential (average analyst target price relative to current price) is higher than 1509.26% of them.
- NUVASIVE INC's variance in analysts' estimates is lower than -2354.65% of Medical Equipment stocks.
In the Medical Equipment industry, INO, IART, and ICUI are the three stocks most similar to NUVASIVE INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is NUVA a Buy, Hold or Sell? See the POWR Ratings now!